Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Christophe

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Blood|August 24, 2006
P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factorRonan Pendu, Virginie Terraube, Olivier D Christophe, et al.
Molecular and Cellular Endocrinology|June 1, 1989
Identification of a cAMP-responsive region in thyroglobulin gene promoterD Christophe, C Gérard, G Juvenal, et al.
Plos One|May 23, 2012
In vivo analysis of the role of O-glycosylations of von Willebrand factorIdinath Badirou, Mohamad Kurdi, Paulette Legendre, et al.
Blood|August 24, 2012
A murine model to characterize the antithrombotic effect of molecules targeting human von Willebrand factorAna-Maria Navarrete, Caterina Casari, Paulette Legendre, et al.
Hormone Research|January 1, 1987
Normal and defective expression of the thyroglobulin geneG Vassart, H Brocas, D Christophe, et al.
Molecular and Cellular Endocrinology|May 1, 1985
Structure, expression and regulation of the thyroglobulin geneG Vassart, A Bacolla, H Brocas, et al.
Journal of Thrombosis and Haemostasis : JTH|August 18, 2009
Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia AA Navarrete, S Dasgupta, S Delignat, et al.
Frontiers in Immunology|April 11, 2020
Removal of Mannose-Ending Glycan at Asn<sup>2118</sup> Abrogates FVIII Presentation by Human Monocyte-Derived Dendritic CellsSandrine Delignat, Julie Rayes, Suryasarathi Dasgupta, et al.
Thrombosis and Haemostasis|July 18, 2014
Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devicesAntoine Rauch, Paulette Legendre, Olivier D Christophe, et al.
Blood|March 5, 2010
Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2BJulie Rayes, Martine J Hollestelle, Paulette Legendre, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Blood|August 24, 2006
P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factorRonan Pendu, Virginie Terraube, Olivier D Christophe, et al.
Molecular and Cellular Endocrinology|June 1, 1989
Identification of a cAMP-responsive region in thyroglobulin gene promoterD Christophe, C Gérard, G Juvenal, et al.
Plos One|May 23, 2012
In vivo analysis of the role of O-glycosylations of von Willebrand factorIdinath Badirou, Mohamad Kurdi, Paulette Legendre, et al.
Blood|August 24, 2012
A murine model to characterize the antithrombotic effect of molecules targeting human von Willebrand factorAna-Maria Navarrete, Caterina Casari, Paulette Legendre, et al.
Hormone Research|January 1, 1987
Normal and defective expression of the thyroglobulin geneG Vassart, H Brocas, D Christophe, et al.
Molecular and Cellular Endocrinology|May 1, 1985
Structure, expression and regulation of the thyroglobulin geneG Vassart, A Bacolla, H Brocas, et al.
Journal of Thrombosis and Haemostasis : JTH|August 18, 2009
Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia AA Navarrete, S Dasgupta, S Delignat, et al.
Frontiers in Immunology|April 11, 2020
Removal of Mannose-Ending Glycan at Asn<sup>2118</sup> Abrogates FVIII Presentation by Human Monocyte-Derived Dendritic CellsSandrine Delignat, Julie Rayes, Suryasarathi Dasgupta, et al.
Thrombosis and Haemostasis|July 18, 2014
Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devicesAntoine Rauch, Paulette Legendre, Olivier D Christophe, et al.
Blood|March 5, 2010
Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2BJulie Rayes, Martine J Hollestelle, Paulette Legendre, et al.
Pageof 15